2 active not recruiting, 2 completed, 2 not yet recruiting. 6 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 6 | Active not recruiting 2, Completed 2, Not yet recruiting 2 |
Follow HCV Infection: new trials by email Literature Review of HCV Infection trials Research Report on HCV Infection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Study to Evaluate the Performance of the INSTI® HCV Antibody Test for CLIA-Waived Use INSTI HCV Antibody Test - HCV Infection | Not applicable | Not yet recruiting | bioLytical Laboratories | 388 | 2026-11-01 | 2026-10-29 |
| Study to Evaluate the Performance of the INSTI® HCV Antibody Test for Point-of-Care Use in Individuals at Risk for HCV Infection or Presenting With Signs or Symptoms of HCV Infection INSTI HCV Antibody Test - HCV Infection | Not applicable | Not yet recruiting | bioLytical Laboratories | 1660 | 2026-11-01 | 2026-10-29 |
| Study of DAA Treatment for Children and Adolescents With Active HCV Infection in Cambodia Sofosbuvir/Daclatasvir - HCV Infection | Not applicable | Active not recruiting | ANRS, Emerging Infectious Diseases | 21000 | 2023-08-07 | 2025-12-04 |
| APPROACH 2.0: HIV, HCV and Syphilis Testing Through Pharmacies Choice of STBBI test(s) - HIV Infections, HCV Infection | Not applicable | Active not recruiting | Memorial University of Newfoundland | 407 | 2022-12-01 | 2024-12-02 |
| A Community-based Intervention Among Active Drug Users in Montpellier HCV screening, Diagnosis of hepatitis C, HCV treatment - Drug Use, HCV Infection | Not applicable | Completed | ANRS, Emerging Infectious Diseases | 554 | 2020-09-18 | 2022-07-22 |
| Kentucky Communities and Researchers Engaging to Halt the Opioid Epidemic (CARE2HOPE) Health Linkage, Overdose Education - Substance Use, HIV Infections | Not applicable | Completed | April M Young | 234 | 2019-11-15 | 2023-12-21 |
Hepatitis C (6) · HIV Infections (2) · Drug Overdose (1) · Hepatitis (1) · Sexually Transmitted Diseases (1) · Substance-Related Disorders (1)
Blood-Borne Infections (6) · Communicable Diseases (6) · Digestive System Diseases (6) · Flaviviridae Infections (6) · Hepatitis, Viral, Human (6) · Infections (6) · Liver Diseases (6) · RNA Virus Infections (6) · Virus Diseases (6) · Hepatitis (5) · Genital Diseases (2) · Immune System Diseases (2) · Immunologic Deficiency Syndromes (2) · Lentivirus Infections (2) · Retroviridae Infections (2)
Sofosbuvir (1) · daclatasvir (1)
ANRS, Emerging Infectious Diseases (2) · bioLytical Laboratories (2) · April M Young (1) · Memorial University of Newfoundland (1)
Cambodia (1) · Canada (1) · France (1) · United States (1)
PMID 35774932, PMID 37720025, PMID 37946233
4UH3DA044798-03 (1)